Page last updated: 2024-10-31

neostigmine and Esophageal Varices

neostigmine has been researched along with Esophageal Varices in 2 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bell, CF1
Hunter, JM1
Jones, RS1
Utting, JE1
Sheft, DJ1

Reviews

1 review available for neostigmine and Esophageal Varices

ArticleYear
Recent advances in clinical diagnostic roentgenology. 2. Pharmacoradiology.
    Advances in surgery, 1971, Volume: 5

    Topics: Angiography; Autonomic Agents; Collateral Circulation; Dextrans; Duodenal Diseases; Duodenal Neoplas

1971

Other Studies

1 other study available for neostigmine and Esophageal Varices

ArticleYear
Use of atracurium and vecuronium in patients with oesophageal varices.
    British journal of anaesthesia, 1985, Volume: 57, Issue:2

    Topics: Adult; Aged; Atracurium; Esophageal and Gastric Varices; Female; Humans; Hypertension, Portal; Intub

1985